Physician profile
Dustin Kelly
NPI 1942987664
$1,229.66
in general payments reported to CMS, 2019-2025
17 companies · $660 in 2025
The $660 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $50.12 · 2024: $519 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,229.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $408.37 | 2024-2025 | |
| Alpha Cognition USA, INC. | $142.88 | 2025 | Zunveyl |
| Lilly USA, LLC | $140.39 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $83.92 | 2024-2025 | Rybelsus, Ozempic |
| Baxter Healthcare | $80.94 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Astrazeneca Pharmaceuticals LP | $56.13 | 2024-2025 | Airsupra, Farxiga |
| Mylan Specialty L.P. | $52.81 | 2024 | Yupelri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.44 | 2025 | Caplyta |
| Corcept Therapeutics | $36.80 | 2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $36.57 | 2024 | Voquezna |
| Inspire Medical Systems, INC. | $32.17 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.35 | 2023-2024 | |
| Pfizer INC. | $22.25 | 2024 | |
| Amgen INC. | $18.49 | 2023 | Repatha, Otezla |
| Ardelyx, INC. | $18.27 | 2025 | Ibsrela |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $17.82 | 2024 | Quviviq |
| Novartis Pharmaceuticals Corporation | $15.06 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.